1. Inicio
  2. Publicaciones
  3. The proportion of prostate-specific antigen (PSA) complexed to alpha(1)-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 microg/L.

The proportion of prostate-specific antigen (PSA) complexed to alpha(1)-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 microg/L.

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Royo M

Abstract

The aim of this study was to assess the diagnostic accuracy of the proportion of prostate-specific antigen (PSA) complexed to alpha(1)-antichymotrypsin (PSA-alpha(1)ACT:PSA ratio) in the differential diagnosis of prostate cancer (CaP) and benign prostatic hyperplasia (BPH) in men with total PSA of 10-30 microg/L.

Datos de la publicación

ISSN/ISSNe:
0009-9147, 1530-8561

CLINICAL CHEMISTRY  OXFORD UNIV PRESS INC

Tipo:
Article
Páginas:
1251-1256
DOI:
PubMed:
12142381
Factor de Impacto:
1,355 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 11

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • DIGITAL RECTAL EXAMINATION; TRANSITION ZONE VOLUME; REFERENCE RANGES; LONGITUDINAL EVALUATION; MOLECULAR-FORMS; IN-VITRO; SERUM; RATIO; ALPHA-1-ANTICHYMOTRYPSIN; DENSITY

Cita

Compartir